HMGA2 expression and response to anthracycline-based preoperative chemotherapy in patients with operable breast cancer

被引：0
|
作者：
Puglisi, F.
Ermacora, P.
Driol, P.
Masolini, P.
Alessi, B.
Pisa, F. E.
Pandolfi, M.
Mansutti, M.
Giancotti, V.
Di Loreto, C.
机构：
[1] Univ Hosp, Udine, Italy
[2] Univ Trieste, Trieste, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.22035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22035
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
    Alain Mina
    Hind Rafei
    Maya Khalil
    Yasmine Hassoun
    Zeina Nasser
    Arafat Tfayli
    BMC Cancer, 15
  • [42] ATHEROGENIC PLASMA INDEX LEVELS IN BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
    Gundogdu, Utku Donem
    Coban, Funda Karabag
    FRESENIUS ENVIRONMENTAL BULLETIN, 2022, 31 (01): : 787 - 791
  • [43] The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients
    Anastasiou, M.
    Oikonomou, E.
    Theofilis, P.
    Papamikroulis, G. A.
    Gazouli, M.
    Pesiridis, T.
    Goliopoulou, A.
    Papatheodoridi, D.
    Psyrri, A.
    Zagouri, F.
    Siasos, G.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [44] Left ventricular diastolic function in patients with breast cancer treated with anthracycline-based chemotherapy
    Mincu, R.
    Lampe, L.
    Rassaf, T.
    Totzeck, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2843 - 2843
  • [45] The effect of anthracycline-based (epirubicin) adjuvant chemotherapy on plasma TAFI and PAI-1 levels in operable breast cancer
    Demirkan, B
    Özcan, MA
    Alacacioglu, A
    Yüksel, F
    Ündar, B
    Alakavuklar, M
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (01) : 9 - 14
  • [46] Exercise training during anthracycline-based chemotherapy for breast cancer.
    Fraser, Steve
    Bigaran, Ashley
    Selig, Steve
    LaGerche, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Szkandera, Joanna
    Absenger, Gudrun
    Dandachi, Nadia
    Regitnig, Peter
    Lax, Sigurd
    Stotz, Michael
    Samonigg, Hellmut
    Renner, Wilfried
    Gerger, Armin
    MOLECULAR GENETICS AND GENOMICS, 2012, 287 (09) : 755 - 764
  • [48] Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
    Nikolenyi, Aliz
    Suekoesd, Farkas
    Kaizer, Laszlo
    Csoergo, Erika
    Voeroes, Andras
    Uhercsak, Gabriella
    Ormandi, Katalin
    Lazar, Gyoergy
    Thurzo, Laszlo
    Brodowicz, Thomas
    Kahan, Zsuzsanna
    ONCOLOGY, 2011, 80 (3-4) : 269 - 277
  • [49] Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Szkandera, J.
    Absenger, G.
    Dandachi, N.
    Regitnig, P.
    Lax, S.
    Stotz, M.
    Winder, T.
    Samonigg, H.
    Renner, W.
    Gerger, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (15-16) : 575 - 575
  • [50] Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Joanna Szkandera
    Gudrun Absenger
    Nadia Dandachi
    Peter Regitnig
    Sigurd Lax
    Michael Stotz
    Hellmut Samonigg
    Wilfried Renner
    Armin Gerger
    Molecular Genetics and Genomics, 2012, 287 : 755 - 764
12345